Mergers & AcquisitionsBoehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Boehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Read Post »
Mergers & AcquisitionsRigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Rigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Read Post »
Health Tidings Mergers & AcquisitionsBMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance BMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance Read Post »
Health Tidings Mergers & AcquisitionsGSK Aligns With CTTQ to Expand Access to Bepirovirsen in China GSK Aligns With CTTQ to Expand Access to Bepirovirsen in China Read Post »
Health Tidings Mergers & AcquisitionsOncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Oncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Read Post »
Mergers & AcquisitionsRoche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Roche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Read Post »
Health Tidings Mergers & AcquisitionsGSK Partners With Halozyme to Develop Subcutaneous ADC Therapies GSK Partners With Halozyme to Develop Subcutaneous ADC Therapies Read Post »
Health Tidings Mergers & AcquisitionsGSK Licenses SiranBio’s siRNA Candidate SA030 in Up to $1 Billion Deal GSK Licenses SiranBio’s siRNA Candidate SA030 in Up to $1 Billion Deal Read Post »
Health Tidings Mergers & AcquisitionsBayer to Acquire Perfuse Therapeutics in Up to USD 2.45 Billion Ophthalmolo... Bayer to Acquire Perfuse Therapeutics in Up to USD 2.45 Billion Ophthalmolo... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme Licenses Hypercon Technology to Oruka Therapeutics for ORKA-001 Halozyme Licenses Hypercon Technology to Oruka Therapeutics for ORKA-001 Read Post »
Health Tidings Mergers & AcquisitionsArrowhead Takes Aim at MASH Genetics with Madrigal Licensing Deal Arrowhead Takes Aim at MASH Genetics with Madrigal Licensing Deal Read Post »
Health Tidings Mergers & AcquisitionsEvotec–Almirall Hit Preclinical Milestone for Skin Disease Therapy Evotec–Almirall Hit Preclinical Milestone for Skin Disease Therapy Read Post »
Health Tidings Mergers & AcquisitionsBioCryst and Neopharmed Gentili Sign Navenibart Deal to Support 2027 Filing BioCryst and Neopharmed Gentili Sign Navenibart Deal to Support 2027 Filing Read Post »
Mergers & AcquisitionsUCB Acquires Candid Therapeutics in $2.2 Billion Autoimmune Deal UCB Acquires Candid Therapeutics in $2.2 Billion Autoimmune Deal Read Post »
Health Tidings Mergers & AcquisitionsUCB Taps IMIDomics to Power Its Precision Medicine Engine UCB Taps IMIDomics to Power Its Precision Medicine Engine Read Post »
Mergers & AcquisitionsChiesi Seals a Strategic Win with $1.9B KalVista Acquisition Chiesi Seals a Strategic Win with $1.9B KalVista Acquisition Read Post »
Mergers & AcquisitionsTeva to Acquire Emalex and Add Tourette Drug Ecopipam Teva to Acquire Emalex and Add Tourette Drug Ecopipam Read Post »
Mergers & AcquisitionsProfluent and Eli Lilly Chase the ‘Holy Grail’ of DNA Editing Profluent and Eli Lilly Chase the ‘Holy Grail’ of DNA Editing Read Post »
Health Tidings Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition BioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition Read Post »
Mergers & AcquisitionsEli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics Deal Eli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics Deal Read Post »
Health Tidings Mergers & AcquisitionsSun Pharma Acquires Organon in $11.75 Billion Deal Sun Pharma Acquires Organon in $11.75 Billion Deal Read Post »
Mergers & AcquisitionsSerum Institute Joins VaxThera to Expand Vaccine Access in Colombia Serum Institute Joins VaxThera to Expand Vaccine Access in Colombia Read Post »
Mergers & AcquisitionsSerum Institute of India Teams with Oxford to Reinforce the Fight Against M... Serum Institute of India Teams with Oxford to Reinforce the Fight Against M... Read Post »
Health Tidings Mergers & AcquisitionsAbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE Read Post »
Mergers & AcquisitionsApotex to Acquire Cumberland’s Branded Drug Portfolio in $100M Deal Apotex to Acquire Cumberland’s Branded Drug Portfolio in $100M Deal Read Post »
Health Tidings Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv Acquisition Amneal Bets Big on Biosimilars with Kashiv Acquisition Read Post »
Mergers & AcquisitionsMerck Builds AI-Enabled Enterprise with Support from Google Cloud Merck Builds AI-Enabled Enterprise with Support from Google Cloud Read Post »
Health Tidings Mergers & AcquisitionsCompass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Compass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Read Post »
Health Tidings Mergers & AcquisitionsBiogen Takes Full Control of Felzartamab from TJ Biopharma Biogen Takes Full Control of Felzartamab from TJ Biopharma Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Read Post »
Health Tidings Mergers & AcquisitionsUCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move UCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move Read Post »
Health Tidings Mergers & AcquisitionsGilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Gilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Read Post »
Health Tidings Mergers & AcquisitionsVir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Vir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Read Post »
Mergers & AcquisitionsAligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Aligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Read Post »
Mergers & AcquisitionsMeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... MeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... Read Post »
Health Tidings Mergers & AcquisitionsIllumina and D3b Construct a Unified Genomic Core to Break Pediatric Data S... Illumina and D3b Construct a Unified Genomic Core to Break Pediatric Data S... Read Post »
Mergers & AcquisitionsBoehringer and Zai Lab Sharpen a Two-Edge Strategy to Cut Through DLL3 Tumo... Boehringer and Zai Lab Sharpen a Two-Edge Strategy to Cut Through DLL3 Tumo... Read Post »
Mergers & AcquisitionsMesoblast Expands Its Cell Therapy Territory with CAR-Powered Precision Pla... Mesoblast Expands Its Cell Therapy Territory with CAR-Powered Precision Pla... Read Post »
Mergers & AcquisitionsGSK’s Bold Lungstrike: Acquiring 35Pharma to Unleash HS235 on PH GSK’s Bold Lungstrike: Acquiring 35Pharma to Unleash HS235 on PH Read Post »
Mergers & AcquisitionsAbbVie Builds Pain Portfolio Through Broad Licensing Pact With Haisco AbbVie Builds Pain Portfolio Through Broad Licensing Pact With Haisco Read Post »
Mergers & AcquisitionsNovo Nordisk Taps OpenAI to Supercharge the Drug Discovery Engine Novo Nordisk Taps OpenAI to Supercharge the Drug Discovery Engine Read Post »
Mergers & AcquisitionsRegeneron and Telix Set 50/50 Course for Targeted Radiopharma Expansion Regeneron and Telix Set 50/50 Course for Targeted Radiopharma Expansion Read Post »
Mergers & AcquisitionsBoehringer, Click Move CT-155 to Frontline in Schizophrenia Boehringer, Click Move CT-155 to Frontline in Schizophrenia Read Post »
Mergers & AcquisitionsFrom Images to Insights: Imagene AI Partners Daiichi Sankyo From Images to Insights: Imagene AI Partners Daiichi Sankyo Read Post »
Mergers & AcquisitionsRoche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer Strategy Roche, C4 Therapeutics Launch “Two-in-One” Targeted Cancer Strategy Read Post »
Mergers & AcquisitionsCosette Pharmaceuticals Acquires SYMPAZAN Portfolio from Assertio Holdings Cosette Pharmaceuticals Acquires SYMPAZAN Portfolio from Assertio Holdings Read Post »
Clinical Trials Mergers & AcquisitionsBoehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Boehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Read Post »
Mergers & AcquisitionsAstellas Taps Dyno’s AI-Designed AAV Capsid to Tackle Muscle Gene Therapy... Astellas Taps Dyno’s AI-Designed AAV Capsid to Tackle Muscle Gene Therapy... Read Post »
Mergers & AcquisitionsShionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fe... Shionogi Secures Up to $482 Million BARDA Project BioShield Contract for Fe... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme and Vertex Sign Global Licensing Deal for Hypercon Drug Delivery T... Halozyme and Vertex Sign Global Licensing Deal for Hypercon Drug Delivery T... Read Post »
